Gunnar Sturfelt (Former)
171 – 180 of 182
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19
(
- Contribution to journal › Article
-
Mark
Novel roles of complement in systemic lupus erythematosus - Hypothesis for a pathogenetic vicious circle
(
- Contribution to journal › Article
- 1999
-
Mark
Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups
(
- Contribution to journal › Article
- 1997
-
Mark
Allvarlig biverkning av metotrexat vid reumatoid artrit. Glöm ej säkerhetsrutiner vid interkurrent sjukdom!
(
- Contribution to journal › Article
- 1996
-
Mark
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 1995
-
Mark
Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]
(
- Contribution to journal › Article
- 1994
-
Mark
Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations
(
- Contribution to journal › Article
- 1993
-
Mark
Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by Podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82)
(
- Contribution to journal › Article